Pancreatic Polypeptide RIA

pPancreatic Polypeptide RIA/p
pimg alt=For Research Use Only src=http://www.alpco.com/img/ruo.gif align=absMiddle / For Research Use Only/p
div class=prod_head_infohr /
/div
div class=prod_spec_box
div class=prod_specFormat:/div
div class=prod_spec_infoRadioimmunoassay/div
/div
div class=prod_spec_box
div class=prod_specSample Type:/div
div class=prod_spec_infoSerum/div
/div
div class=prod_spec_box
div class=prod_specbSample Size:/b/div
div class=prod_spec_info100 micro;l/div
/div
div class=prod_spec_box
div class=prod_specbSize:/b/div
div class=prod_spec_info100 Tubes/div
/div
div class=prod_spec_box
div class=prod_specbRange:/b/div
div class=prod_spec_info6.25 - 200 pmol/l/div
/div
div class=prod_spec_box
div class=prod_specbSensitivity:/b/div
div class=prod_spec_info3 pmol/l/div
/div
div class=prod_spec_box
div class=prod_specbIncubation Time:/b/div
div class=prod_spec_infoOvernight/div
div class=prod_spec_info
pbSummary:/b/p
Pancreatic Polypeptide (PP) RIA - The intended use of these reagents is for assay of PP in human Serum. PP in Serum is assayed without extraction by a competetive radioimmunoassay using a rabbit antiSerum raised against bovine PP. PP in standards and samples compete with 125I-labelled human PP in binding to the antibodies. 125I-PP binds in a reverse proportion to the concentration of PP in standards and samples. Antibody-bound 125I-PP is separated from the unbound fraction using the double antibody-polyethyleneglycol precipitation technique. The radioactivity of the precipitates is measured. Human, synthetic PP is used for standardization./div
/div